You may also like
Harvest Technologies’ case in the U.S. District Court in Massachusetts is proceeding to trial November 29th on the issue of the invalidity of Cytomedix, Inc’s U.S. Patent No. 5,165,938
Harvest Technologies’ case in the U.S. District Court in Massachusetts is proceeding to trial on the issue of the invalidity of Cytomedix, Inc’s U.S. Patent No. 5,165,938 (the Knighton Patent).
1 min read
Using Autologous Platelet-Rich Plasma for the Treatment of Complex Fistulas
This study aims to demonstrate the effectiveness and safety of autologous fibrin gel rich in platelet growth factors for the treatment of complex perianal fistulas.
1 min read
Reduction in blood transfusion in a cohort of infants having cardiac surgery with cardiopulmonary bypass after instituting a goal-directed transfusion policy.
Current trends in pediatric cardiac surgery and anesthesiology include goal-directed allogeneic blood transfusion, but few studies address the transfusion of platelets and cryoprecipitate.
1 min read